C12ORF48 AS A TARGET GENE FOR CANCER THERAPY AND DIAGNOSIS
    12.
    发明公开
    C12ORF48 AS A TARGET GENE FOR CANCER THERAPY AND DIAGNOSIS 审中-公开
    C12ORF48作为靶基因用于癌症治疗和诊断

    公开(公告)号:EP2352825A1

    公开(公告)日:2011-08-10

    申请号:EP09809511.0

    申请日:2009-08-21

    IPC分类号: C12N15/09

    摘要: Objective methods for diagnosing a predisposition to developing pancreatic cancer and prostate cancer, particularly pancreatic ductal adenocarcinoma (PDAC) and castration-resistant prostate cancer, are described herein. In one embodiment, the diagnostic method involves the step of determining an expression level of C12ORF48 using siRNAs targeting the C12ORF48 gene. The invention also features products such as siRNAs as well as to compositions containing them. The present invention further provides methods of screening for therapeutic agents useful in the treatment of C12ORF48 associated disease, such as a cancer, e.g. pancreatic cancer and prostate cancer, as well as methods of inhibiting the cell growth and treating or alleviating one or more disease symptoms. The invention also features products such as double stranded molecules, as well as vectors and compositions containing them.

    TREATING OR PREVENTING CANCERS OVER-EXPRESSING REG4 OR KIAA0101
    15.
    发明公开
    TREATING OR PREVENTING CANCERS OVER-EXPRESSING REG4 OR KIAA0101 审中-公开
    治疗或预防癌症有关表达REG4或KIAA0101

    公开(公告)号:EP2059593A2

    公开(公告)日:2009-05-20

    申请号:EP07792516.2

    申请日:2007-08-08

    摘要: The invention features a method for inhibiting growth of a cancer cell by contacting the cell with a composition of an siRNA that inhibits expression of REG4 or KIAA0101. Methods of treating cancer are also within the invention. The invention also features products, including nucleic acid sequences and vectors as well as to compositions comprising them, useful in the provided methods. The invention also provides a method for inhibiting of tumor cell, for example pancreatic cancer cell, prostatic cancer cell, breast cancer cell, and bladder cancer cell, particularly pancreatic ductal adenocarcinoma (PDAC) by inhibiting REG4 gene. The present invention also relates to methods of treating or preventing PDAC in a subject comprising the step of administering to said subject a pharmaceutically effective amount of an antibody or fragment thereof that binds to a protein encoded by REG4. The present invention also relates to methods of diagnosing chemo-radiation therapeutic resistance of a cancer. The present invention also provides therapeutic agents or methods for treating cancer using the polypeptides. The polypeptides of the present invention are composed of an amino acid sequence which comprises polypeptide which comprises QKGIGEFF/SEQ ID NO: 21. The polypeptides of the present invention can be introduced into cancer cells by modifying the polypeptides with transfection agents such as poly-arginine.